Author(s):
Sarika R. Jadhav, Shashikant N. Dhole, Hemant P. Alhat, Nilesh S. Kulkarni
Email(s):
jadhavsarikapharma@gmail.com
DOI:
10.52711/0974-360X.2025.00872 
Address:
Sarika R. Jadhav*, Shashikant N. Dhole, Hemant P. Alhat, Nilesh S. Kulkarni
PES’s Modern College of Pharmacy, For Ladies, Moshi, Pune.
*Corresponding Author
Published In:
Volume - 18,
Issue - 12,
Year - 2025
ABSTRACT:
The telmisartan and azelnidipine are the drugs used in combination for the treatment of hypertension. Telmisartan is an angiotensin II receptor blocker and azelnidipine is a calcium channel blocker, together in combination they reduce the augmentation index. For this combination, the author developed novel analytical methods like the simultaneous equation method and absorbance ratio (Q) method for simultaneous estimation of telmisartan and azelnidipine by UV spectrophotometry using methanol: distilled water (50:50) as a solvent. The maximum absorption was found 295±1 nm and 255±1nm for telmisartan and azelnidipine respectively; the isosbestic point was found at 275±1nm. Both methods were linear in the range of 2-12µg/ml for telmisartan and 6-16µg/ml for azelnidipine. Different validation parameters of both methods were validated as per the International Conference on Harmonization guidelines. The results found were statistically analyzed and validated which were found within the range (%RSD = 2). These developed and validated methods were found to be reliable and reproducible. Hence it can be used for simultaneous estimation of telmisartan and azelnidipine in bulk and combined dosage form.
Cite this article:
Sarika R. Jadhav, Shashikant N. Dhole, Hemant P. Alhat, Nilesh S. Kulkarni. Development and Validation of Novel Simultaneous Equation and Absorbance Ratio Method for Simultaneous Estimation of Telmisartan and Azelnidipine for Bulk and Pharmaceutical Dosage form using UV Spectrophotometry. Research Journal Pharmacy and Technology. 2025;18(12):6035-1. doi: 10.52711/0974-360X.2025.00872
Cite(Electronic):
Sarika R. Jadhav, Shashikant N. Dhole, Hemant P. Alhat, Nilesh S. Kulkarni. Development and Validation of Novel Simultaneous Equation and Absorbance Ratio Method for Simultaneous Estimation of Telmisartan and Azelnidipine for Bulk and Pharmaceutical Dosage form using UV Spectrophotometry. Research Journal Pharmacy and Technology. 2025;18(12):6035-1. doi: 10.52711/0974-360X.2025.00872 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2025-18-12-62
REFERENCES:
1. Guerrero-García C, Rubio-Guerra AF. Combination therapy in the treatment of hypertension. Drugs Context. 2018; June 6; 7: 212531. doi: 10.7573/dic.212531
2. Sharpe M, et al. Telmisartan: a review of its use in hypertension. Drugs. 2001; 61(10): 1501-29. doi: 10.2165/00003495-200161100-00009
3. Chen BL, et al. Clinical use of azelnidipine in the treatment of hypertension in Chinese patients. Ther Clin Risk Manag. 2015; 11: 309-18. doi:10.2147/TCRM.S64288.
4. Ram, C.V.S. Therapeutic Usefulness of a Novel Calcium Channel Blocker Azelnidipine in the Treatment of Hypertension: A Narrative Review. Cardiol Ther 2022 Dec; 11 (4): 473–89. doi: 10.1007/s40119-022-00276-4
5. Sheetal, et al. Validation of Telmisartan by UV Spectrophotometry Method. Research Journal of Pharmacy and Technology. 2019; 12(5): 2413-5. doi: 10.5958/0974-360X.2019.00404.9 available on: https://rjptonline.org/AbstractView.aspx?PID=2019-12-5-63
6. A. Sai Susmitha, et al. Spectrophotometric Quantification of Telmisartan Employing Multivariate Calibration Technique in Bulk and Pharmaceutical Formulations. Research J. Pharm. and Tech. 2019; 12(4): 1799-805. doi: 10.5958/0974-360X.2019.00300.7 Available on: https://rjptonline.org/AbstractView.aspx?PID=2019-12-4-55
7. Santosh KV, et al. New Validated UV- Spectrophotometric Method for the Determination of Telmisartan in Bulk and Dosage Form. Research J. Pharm. and Tech. 2012; 5(9): 1209-12
8. Vanaja N, et al. Method Development and Validation for Simultaneous Estimation of Telmisartan and Ramipril by UV-Spectrophotometric Method in Pharmaceutical Dosage Form. Asian J. Pharm. Ana. 2015; 5(4): 187-94
9. Daharwal SJ, Singh VD. Development of Chemometric Assisted Methods for Simultaneous Estimation of Ternary mixture of Telmisartan hydrochloride, Amlodipine besylate and Hydrochlorothiazide. Asian J. Pharm. Tech. 2015; 5(2): 122-6
10. N. Vanaja, et al. Method Development and Validation for Simultaneous Estimation of Telmisartan and Chlorthalidone by RP-HPLC in Pharmaceutical Dosage Form. Asian J. Pharm. Ana. 2015; 5(4): 171-7. doi: 10.5958/2231-5675.2015.00027.7 available on: https://ajpaonline.com/AbstractView.aspx?PID=2015-5-4-1
11. P. Kalaiselvi, et al. HPTLC Method for Simultaneous Determination of Pioglitazone HCl and Telmisartan in Tablet Dosage Form. Asian J. Research Chem. 2010; 3(1): 60-2. available on: https://ajrconline.org/AbstractView.aspx?PID=2010-3-1-15
12. Kamalakannan D, et al. Simultaneous Estimation of Telmisartan and Pioglitazone in Pharmaceutical Dosage Form by RP-HPLC Method. Asian J. Research Chem. 2010; 3(2): 364-6
13. Dyade GK, et al. A QBD Approach in Chemometric assisted Method Development of Telmisartan and Amlodipine besylate by UV-VIS Spectrophotometry. Asian Journal of Pharmacy and Technology. 2022; 12(3): 218-4
14. P. Suthar, R. Mashru. Advanced UV Spectrophotometric Method Development and Validation for Simultaneous Estimation of Azelnidipine and Telmisartan in Pharmaceutical Dosage Form. Indian Journal of Pharmacy and Drug Studies. 2023; 2 (1): 27-32. available on https://mansapublishers.com/index.php/ijpds/article/view/3602
15. S. Ahmad, N. et al. Analytical Method Development and Validation for the Simultaneous Estimation of Azelnidipine and Telmisartan by RP-HPLC in Bulk and Tablet Dosage Forms. Research Journal of Pharmacy and Technology. 2022; 15(12): 5736-0. doi: 10.52711/0974-360X.2022.00967 available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-12-61
16. M. Kumar, et al. Development and Validation of In-vitro dissolution test using RP-HPLC Analysis for simultaneous estimation of Azelnidipine and Telmisartan in a Fixed-dose Combination. Research Journal of Pharmacy and Technology. 2022; 15(5): 1967-2. doi: 10.52711/0974-360X.2022.00327 available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-5-9
17. Bavishi P, et al. An Updated Review on Analytical Methods for the Azelnidipine and Telmisartan in Pharmaceutical Dosage Form. International Journal of Pharmaceutical Sciences and Research. 2023; 11: 4431- 43. doi:10.13040/IJPSR.0975-8232. 14(9). 4331-43
18. Rajesh ZM. Analytical Method Development and Validation of Pharmaceutical Technology: An Overview. Research J. Pharma. Dosage Forms and Tech. 2013; 5(4): 213-20
19. Validation of analytical procedure: Methodology Q2B. In: ICH Harmonized Tripartite Guidelines. Geneva, Switzerland. 1996; 1-8
20. Sharma A, Sharma R. Validation of analytical procedures: A comparison of ICH Vs Pharmacopoiea (USP) Vs FDA. International Research Journal of Pharmacy. 2012; 3(6): 39-42
21. Jadhav SR, et al. Analytical methods development and validation for simultaneous estimation of Lopinavir and Ritonavir in pharmaceutical formulation by simultaneous equation method using UV spectrophotometry. Int. Res. J. Pharm. 2018; 9(8): 57-62. doi:10.7897/2230-8407.098165
22. P. Patil, S. et al. Simultaneous UV Spectrophotometric Method for Estimation of Losartan Potssium and Amlodipine Besylate in Tablet Dosage Form. Asian J. Research Chem. 2009; 2(2): 183-7 available on: https://www.ajrconline.org/AbstractView.aspx?PID=2009-2-2-23
23. S. Patel, C. Patel. Development and Validation of Zero Absorbance Method for Simultaneous Estimation of Aliskiren and Amlodipine in Combined Dosage Form. Asian J. Pharm. Ana. 2016; 6(3): 138-42. available on: https://ajpaonline.com/AbstractView.aspx?PID=2016-6-3-2
24. PA. Patil, et al. Q-Absorbance Ratio Spectrophotometric method for Simultaneous Determination of Atenolol and Ivabradine HCl in synthetic mixture. Asian J. Res. Pharm. Sci. 2016; 6(1): 27-33
25. Skoog DA, Holler FJ, Timothy A, Nieman NW. Principal of Instrumental Analysis. Eastern Press, New Delhi. 2007.